SNS-INSIDER-300X300.jpg
Cell & Gene Therapy Manufacturing Services Market Size Worth US$ 70.7 Billion by 2032, Amid Rising Clinical Trials | Research by SNS Insider
September 17, 2024 08:45 ET | SNS Insider pvt ltd
Pune, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cell & Gene Therapy Manufacturing Services Market Analysis: “The Cell & Gene Therapy Manufacturing Services Market is experiencing rapid growth,...
1-primary-large-dark.jpg
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
September 16, 2024 07:00 ET | Abata
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
22157.jpg
Cell Therapy Manufacturing Market Historical Trends (2022-2023) and Forecasted Estimates (2024-2035)
September 16, 2024 05:12 ET | Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells,...
NMDP
NMDP℠ Organizes Nationwide Fundraisers to Propel Research, Aid Patients with Blood Cancer and Diseases
September 13, 2024 09:00 ET | NMDP
NMDP, a global leader in cell therapy, will host its first-ever community event series, NMDP: Unite to help find cures for blood cancers and diseases.
Avid Logo June 2022.jpg
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
September 09, 2024 16:05 ET | Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Immatics Final logo (R)_white_background.png
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 06, 2024 07:00 ET | https://immatics.com/
Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and...
laverock_logo-640w.png
Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule
September 05, 2024 04:00 ET | Laverock Therapeutics
STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
SNS-INSIDER-300X300.jpg
Cell Therapy Market Size to Hit USD 28.98 Billion by 2032, Driven by Advances in Personalized Medicine and Stem Cell Applications | SNS Insider
September 04, 2024 09:00 ET | SNS Insider pvt ltd
Pune, Sept. 04, 2024 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Cell Therapy Market, valued at USD 4.65 billion in 2023 and is projected to reach USD 28.98 billion by 2032, driven by a...
Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
September 03, 2024 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...